2025 Drug Shortage Guardian Award Honors Federal Heroes Who Saved Lives During IV Fluid Crisis
Agencies recognized by patient advocacy organization, Angels for Change, for swift action and lifesaving logistics following hurricanes Helene and Milton.
Angels for Change (A4C) announces the pilot launch of Project GOLD (Generic Oncology Lifesaving Drugs), a new resiliency program that establishes an onshore buffer supply of six essential medications that are used to treat cancer. Project GOLD was created to offer physicians and patients stability of care during a shortage through emergency supply at leading distributors and manufacturers. A4C is participating with founding pilot members, pharmaceutical wholesalers Cencora and McKesson, and pharmaceutical and medtech manufacturer Fresenius Kabi.
Angels for Change (A4C) announces its 2024 Change Maker of the Year Award , Lindsey Thomas, Senior Vice President of Marketing at Fresenius Kabi USA. Lindsey was recognized for her exceptional leadership, collaborative spirit, and unwavering commitment to patient care, particularly in addressing the critical chemotherapy drug shortages during 2023 and 2024.
Every day clinicians wonder if they will have the necessary medicines to treat the patients they serve, which include pediatric cancer patients. Far too often, an oncologist has to treat a pediatric cancer patient with a therapy that is not optimal. As a parent, how would you like to hear that your child has cancer, but the best drug to treat your child is not available and that a suboptimal treatment must be administered? —Martin Van Trieste
Angels for Change has been working closely with the FDA to communicate updates on the recently reported vincristine crisis. We are pleased to announce that both the FDA and Pfizer have worked together to provide supply and updates to patients, providers and the community regarding this critical drug shortage.
